A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BREAST CANCER

摘要

The present invention relates to a pharmaceutical combination comprising two cytotoxic antineoplastic agents, gemcitabine and carboplatin, and at least one cyclin dependent kinase (CDK) inhibitor; wherein said combination exhibits synergistic effects when used in the treatment of breast cancer, particularly triple negative breast cancer. The invention also relates to a method for the treatment of breast cancer, using a therapeutically effective amount of said combination.